Page 51 - Status Report
P. 51

The Context


               Cervical cancer occurs when abnormal cells
               on the cervix grow out of control. Most cervical
               cancers  are  caused  by  a  virus  called  the
               Human Papillomavirus, or HPV. Cervical Cancer
               is the largest killer cancer for women in India,
               making India the Cervical Cancer capital of
               the world. With an estimated 350million Indian
               women aged between 21-65 years in the risk
               category for Cervical Cancer; India is potentially
               sitting on a ticking time-bomb. Like in the
               case of most other cancers, early diagnosis
               and  treatment  is  critical  for  favourable
               outcomes. For winning the war against cervical
               cancer,diagnostic tests for cervical cancer have
               to be easy, available at the point-of-care and
               affordable.






                                                          The Initiative

                                                          The project proposes to build an affordable and
                                                          portable, ‘point-of-care’ Cervical Cancer Screening
                                                          tool to automate the analysis of the Pap smear
                                                          slides. The slides are stained,scanned, digitized and
                                                          then analyzed using computer algorithms to triage
                                                          them into normal, suspect and abnormal samples.
                                                          The images are then sent over a Tele-pathology
                                                          medium to pathologists for further confirmations
                                                          and recommendations. Multiple sites around rural
                                                          and urban Karnataka will be included in the initial
                                                          trial. Each site will receive a kit that includes Aindra’s
                                                          Auto Staining Device, Alexapath’s Slide Scanning
                                                          Equipment and a computer with a powerful graphics
                                                          processing unit to run the auto diagnostic. This kit
                                                          will pair semi-skilled workers capable of preparing
                                                          and scanning slides with robotics and a machine
                                                          learning/computer vision artificial intelligence. The
                                                          team aims to bring the cost of cytology down to
                                                          approximately INR 150 per diagnosis, a cost that
                                                          should be affordable for women across rural India.






               The Outcome

               The team has completed the development associated to hardware and have created a web
               application to allow for control of the ADA stage. They have successfully developed a concept
               prototype with established repeatability, positional accuracy, stabilized mechanical and electronic
               components. The team has also developed the ability to accept tiled images from an Image
               Acquisition Device and feed them into the program.






                 Status Report                                                                    51
   46   47   48   49   50   51   52   53   54   55   56